Tuesday 11 November 2008

Glaxo steps up job cuts with UK factory closure

LONDON (Reuters) - GlaxoSmithKline, the world's second biggest drugmaker, said on Tuesday it planned to close its Dartford manufacturing site in south-east England by 2013 with the loss of 620 jobs.

The decision to close the facility reflects falling demand for drugs made at the site as patents expire. It is part of an ongoing review of operations across the group by Chief Executive Andrew Witty, who has made increased efficiency a priority.

Last week, Glaxo told staff it was axing 1,000 sales jobs in the United States by the end of 2008, as it reorganises the operation there to compete in an increasingly tough market.

Earlier this year, it announced plans for 1,200 job cuts in research and development.

Posted by Harsh at 11:24

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)
DISCLAIMER: The author is not a registered stockbroker nor a registered advisor and does not give investment advice. His comments are an expression of opinion only and should not be construed in any manner whatsoever as recommendations to buy or sell a stock, option, future, bond, commodity, index or any other financial instrument at any time. While he believes his statements to be true, they always depend on the reliability of his own credible sources. The author recommends that you consult with a qualified investment advisor, one licensed by appropriate regulatory agencies in your legal jurisdiction, before making any investment decisions, and that you confirm the facts on your own before making important investment commitments.